ChartMill assigns a Buy % Consensus number of 73% to AIMT. The Buy consensus is the weighted average rating of the current analysts ratings.
The consensus rating for Aimmune Therap (AIMT) is 73.4 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering Aimmune Therap (AIMT) is 9.